Chandrasekaran Sruthi, Ruggiero Samantha, Goodrick Gabrielle
Ibis Reproductive Health, Cambridge, MA, USA.
Camelback Family Planning, Phoenix, AZ, USA.
Contracept X. 2024 Feb 17;6:100104. doi: 10.1016/j.conx.2024.100104. eCollection 2024.
Document the clinical outcomes of an outpatient medical management with procedural evacuation backup procedure for abortions between 18 weeks zero days to 23 weeks six days gestation.
We conducted a retrospective medical records review of adult patients who received mifepristone and repeated misoprostol for second trimester abortion with procedural evacuation backup at an Arizona clinic between October 2017 and November 2021. We extracted patient demographics; pregnancy and medical history; and preoperative, intraoperative, and postoperative data. We assessed abortion outcomes, including procedure timing, mode of completion (medication alone or medications and procedural evacuation), and safety.
All 359 patients had a complete abortion with 63.5% of patients completing with medication alone and 36.5% with procedural evacuation backup. The median time from first dose of misoprostol to fetal expulsion was six hours, among those who completed the abortion with medications alone. Of those who received procedural evacuation as backup, the median time for procedural evacuation was 10 minutes. The vast majority of patients (99.4%) did not have any adverse events. Two safety incidents (0.6%) occurred, a broad right ligament tear and a uterine rupture.
Patients in one outpatient setting safely and effectively received medical management of second trimester abortion with procedural evacuation backup, and two thirds completed with medications alone.
Outpatient settings may consider medical management of abortion between 18 and 24 weeks with procedural evacuation back-up as a safe, effective, and manageable second trimester abortion option. Additional research is needed on patient experience and satisfaction.
记录妊娠18周0天至23周6天期间采用药物流产并辅以手术清宫作为备用方案的门诊医疗管理的临床结局。
我们对2017年10月至2021年11月期间在亚利桑那州一家诊所接受米非司酮和重复使用米索前列醇进行中期妊娠流产并辅以手术清宫作为备用方案的成年患者进行了回顾性病历审查。我们提取了患者的人口统计学信息、妊娠和病史以及术前、术中和术后数据。我们评估了流产结局,包括手术时间、完成方式(仅药物流产或药物流产加手术清宫)和安全性。
所有359例患者均完全流产,63.5%的患者仅通过药物流产完成,36.5%的患者辅以手术清宫。在仅通过药物流产完成流产的患者中,从第一剂米索前列醇到胎儿排出的中位时间为6小时。在接受手术清宫作为备用方案的患者中,手术清宫的中位时间为10分钟。绝大多数患者(99.4%)没有任何不良事件。发生了两起安全事件(0.6%),一例阔韧带右支撕裂和一例子宫破裂。
在一个门诊环境中,患者安全有效地接受了中期妊娠流产的药物管理并辅以手术清宫作为备用方案,三分之二的患者仅通过药物流产完成。
门诊环境可考虑将妊娠18至24周的流产药物管理并辅以手术清宫作为一种安全、有效且可管理的中期妊娠流产选择。需要对患者体验和满意度进行更多研究。